Oxybutynin for Neurogenic Bladder

Safety and effectiveness of oxybutynin in children (6-16 years) with neurogenic bladder

Who may qualify:

Patients 6-16 years old with neurogenic detrusor overactivity

Who does not qualify:

Patients who are pregnant, involved in other investigational studies or have certain medical conditions

Medication Under Study:
Oxybutynin Chloride

Full IRB Study Title:
A Multi-Center, Double-Blind, Placebo-Controlled, Dose-Titration Study Evaluating the Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of Oxybutynin Chloride Topical Gel for the Treatment of Detrusor Overactivity Associated with a Neurological Condition in Pediatric Subjects

IRB Study ID:

If you are interested in this study or have questions about your child's eligibility, please contact:

Rebecca D. Considine Research Institute, 330-543-5012

or, Rebecca D. Considine Research Institute, 330-543-5012

Lead Principal Investigator:

Daniel McMahon, MD
Director, Pediatric Urology

Bookmark and Share

Developments Developments
Sign up for enewsletter
Get involved Get involved
Discover ways to support Akron Children's
Join the conversation Join the conversation
See what our patient families are saying
    Contact Us



    find a location
    Find a location Type the first 3-5 letters of a specialty, service or location:
    Or, view: a map, a list of all locations, locations by city or locations near me.
    find a doctor
    Find a doctor Type the first 3-5 letters of the name, location or specialty:
    Or, view a list of all doctors by name, location and specialty.